EUS-guided choledochoduodenostomy by use of electrocautery-enhanced lumen-apposing metal stents: a French multicenter study after implementation of the technique (with video).


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
07 2020
Historique:
received: 18 08 2019
accepted: 27 01 2020
pubmed: 23 2 2020
medline: 10 3 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

EUS-guided biliary drainage is indicated in cases of impossibility or failure of classic biliary drainage by ERCP. Recently we reported good efficiency of EUS-guided choledochoduodenostomy (EUS-CDS) using the electrocautery-enhanced lumen-apposing metal stent (ECE-LAMS) in a retrospective multicenter study. Use of the recommended technique (direct puncture with the ECE-LAMS with use of a pure cut current and a 6-mm stent) was the only predictive factor of clinical success. We re-evaluated this procedure after 1 year in the same centers. This was a French retrospective multicenter study of a prospective database including all cases of EUS-guided CDS with ECE-LAMS in the 7 centers that participated in the first study. Seventy consecutive patients were included in this study between September 1, 2017, and September 22, 2018. Failure of primary ERCP was due to duodenal stenosis in 44% of cases and to tumoral infiltration of the papilla in 22% of cases. The mean duration of the procedure was 5 ± 3 minutes. The recommended technique was used in 98.5% of cases. The technical and clinical success rates were both 97.1% (69/70). Short-term adverse events (periprocedural and intrahospital) occurred in 1.6%. EUS-CDS with the ECE-LAMS is efficacious and safe in distal malignant obstruction of the common bile duct in cases of ERCP failure with impressive results once expertise is acquired and the recommended technique (direct fistulotomy, pure cut current, and 6-mm stent) is followed.

Sections du résumé

BACKGROUND AND AIMS
EUS-guided biliary drainage is indicated in cases of impossibility or failure of classic biliary drainage by ERCP. Recently we reported good efficiency of EUS-guided choledochoduodenostomy (EUS-CDS) using the electrocautery-enhanced lumen-apposing metal stent (ECE-LAMS) in a retrospective multicenter study. Use of the recommended technique (direct puncture with the ECE-LAMS with use of a pure cut current and a 6-mm stent) was the only predictive factor of clinical success. We re-evaluated this procedure after 1 year in the same centers.
METHODS
This was a French retrospective multicenter study of a prospective database including all cases of EUS-guided CDS with ECE-LAMS in the 7 centers that participated in the first study.
RESULTS
Seventy consecutive patients were included in this study between September 1, 2017, and September 22, 2018. Failure of primary ERCP was due to duodenal stenosis in 44% of cases and to tumoral infiltration of the papilla in 22% of cases. The mean duration of the procedure was 5 ± 3 minutes. The recommended technique was used in 98.5% of cases. The technical and clinical success rates were both 97.1% (69/70). Short-term adverse events (periprocedural and intrahospital) occurred in 1.6%.
CONCLUSIONS
EUS-CDS with the ECE-LAMS is efficacious and safe in distal malignant obstruction of the common bile duct in cases of ERCP failure with impressive results once expertise is acquired and the recommended technique (direct fistulotomy, pure cut current, and 6-mm stent) is followed.

Identifiants

pubmed: 32084411
pii: S0016-5107(20)30133-4
doi: 10.1016/j.gie.2020.01.055
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-141

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Jérémie Jacques (J)

service d'Hépato-gastro-entérologie, CHU Dupuytren, Limoges, France.

Jocelyn Privat (J)

service d'Hépato-gastro-entérologie, CH Jacques Lacarin, Vichy, France.

Fabien Pinard (F)

service d'Hépato-gastro-entérologie, Hopital de Cournouaille, Quimper, France.

Fabien Fumex (F)

service d'Hépato-gastro-entérologie, Hopital Privé Jean Mermoz, Lyon, France.

Ulriika Chaput (U)

service d'Hépato-gastro-entérologie, CHU Saint Antoine, Paris, France.

Jean-Christophe Valats (JC)

service d'Hépato-gastro-entérologie, CHU Saint-Eloi, Montpellier, France.

Franck Cholet (F)

service d'Hépato-gastro-entérologie, CHU Brest, Brest, France.

Julien Jezequel (J)

service d'Hépato-gastro-entérologie, CHU Brest, Brest, France.

Philippe Grandval (P)

service d'Hépato-gastro-entérologie, Hopital La Timone, Assistance Publique des Hopitaux de Marseille, Marseille, France.

Romain Legros (R)

service d'Hépato-gastro-entérologie, CHU Dupuytren, Limoges, France.

Hugo Lepetit (H)

service d'Hépato-gastro-entérologie, CHU Dupuytren, Limoges, France.

Jeremie Albouys (J)

service d'Hépato-gastro-entérologie, CHU Dupuytren, Limoges, France.

Bertrand Napoleon (B)

service d'Hépato-gastro-entérologie, Hopital Privé Jean Mermoz, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH